CO2 Monitor Flags Several Medical Conditions

The changing CO2 content of a breath creates a waveform shape of the inhalation and exhalation that has been established as an indicator for several medical conditions. Called capnography, the equipment needed to detect this is large, expensive, and mains-powered, which has restricted its use to monitoring anaesthesia in operating theatres and critical care.


Gas Sensing Solutions (GSS) is changing this with its CO2 sensor technology. The company uses a specially developed LED as the light source at the heart of the sensor. As this can turn on and off almost instantaneously, readings can be taken at more than 50 times a second. Also, the LED requires very little power, enabling battery-powered CO2 sensing devices to be created with long battery lives.

Free Newsletter

Like this article? Subscribe to FierceSensors!

The sensors industry is constantly changing as innovation runs the market’s trends. FierceSensors subscribers rely on our suite of newsletters as their must-read source for the latest news, developments and analysis impacting their world. Register today to get sensors news and updates delivered right to your inbox.


This breakthrough in CO2 sensing is being commercialized for the medical market by GSS' sister company, Cambridge Respiratory Innovations Limited (CRiL). GSS has exclusively developed an ultra-fast, compact version of its SprintIR 6S CO2 sensor for CRiL to provide the level of accuracy needed to produce detailed waveforms and to work in the challenging medical environment. This has enabled CRiL to develop a hand-held personal respiratory monitor, called N-Tidal™, which analyses CO2 levels in normal tidal breathing. For more details, visit Gas Sensing Solutions.


Suggested Articles

Fieldscale’s SENSE development platform will lower design time and costs, companies claim

Avnet posted GAAP earnings per share from continuing operations of 5 cents per share on sales of $4.5 billion, down from a year ago.

Data Center group reached 4Q record at Intel, at $7.2 billion